MedicaidAdministrativeMedium impact
Medicaid Alert - MA-1993-01
New Jersey Medicaid·NJ · Hematology, Oncology·Pharmacy
We identified it
Jun 20, 2026
Summary
New Jersey Medicaid has implemented new billing procedures specifically for antihemophiliac drug claims. This affects how pharmacy-related billing must be processed for hemophilia treatments under Medicaid.
Action Required
Immediately: Billing team must review the complete MA-1993-01 policy document at https://www.njmmis.com/documentDownload.aspx?document=ma1993-01.pdf to understand new antihemophiliac drug billing procedures. Update billing workflows for hemophilia drug claims according to the new requirements. Ensure staff processing pharmacy claims are trained on the updated procedures.